Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Drug Regulation01:25

Drug Regulation

1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causality-Guided Diffusion and Fusion of incomplete multi-modal data for robust survival prognosis.

Medical image analysis·2026
Same author

FGFR2 Regulates Liver Injury and Repair in a Model of Obstructive Jaundice.

Frontiers in bioscience (Landmark edition)·2026
Same author

Ampere-Level Acetylene-to-Ethylene Electrosynthesis by a Spillover-Storage-Relaxation Hydrogenation Mechanism to Overcome the Activity-Selectivity Constraint.

Journal of the American Chemical Society·2026
Same author

Global, Regional, and National Burden of COPD Attributable to Secondhand Smoke from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.

COPD·2026
Same author

Improving low-phosphate tolerance via tissue-specific CRISPR/Cas9 knockout to balance growth and stress responses in rice.

The Plant cell·2026
Same author

Embedded 3D Superionic Network Enables Pressure-Free Solid-State Sodium Batteries with Ultrafast Na<sup>+</sup> Diffusivity over a Wide Temperature Range.

ACS nano·2026

Related Experiment Video

Updated: Sep 15, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Pretraining-Based Relevance-Aware Visit Similarity Network for Drug Recommendation.

Yichen He, Shoubin Dong, Yuchen Lin

    IEEE Journal of Biomedical and Health Informatics
    |July 18, 2025
    PubMed
    Summary

    This study introduces RaVSNet, a novel approach for electronic health record (EHR) drug recommendation. It enhances patient modeling by considering visit similarity and medical relevance, leading to more accurate medication suggestions.

    More Related Videos

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    586
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K

    Related Experiment Videos

    Last Updated: Sep 15, 2025

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.7K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    586
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K

    Area of Science:

    • Biomedical Informatics
    • Artificial Intelligence in Healthcare
    • Clinical Decision Support

    Background:

    • Electronic Health Records (EHR) enable drug recommendation but face challenges due to sparse data and ambiguous patient similarity.
    • Precise patient modeling is crucial, requiring analysis of disease progression and similar patients' medication histories.

    Purpose of the Study:

    • To develop an advanced drug recommendation system that overcomes limitations in EHR data.
    • To improve the accuracy and relevance of drug suggestions by integrating visit similarity and medical knowledge.

    Main Methods:

    • Proposed RaVSNet (Relevance aware Visit Similarity Network) leveraging longitudinal and transversal visit similarity.
    • Integrated medical relevance knowledge and employed a relevance-aware network for condition-medication matching.
    • Introduced a pretraining framework with Medication Sequence Reconstruction (MSR) and Causal Effect Inference (CEI) tasks.

    Main Results:

    • RaVSNet demonstrated superior performance over state-of-the-art methods on MIMIC-III and MIMIC-IV datasets.
    • Achieved more accurate drug recommendation combinations.
    • The pretraining framework improved performance when integrated with other drug recommendation methods.

    Conclusions:

    • RaVSNet effectively addresses challenges in EHR-based drug recommendation through enhanced patient modeling.
    • The proposed pretraining framework offers a generalizable method to boost drug recommendation performance.
    • This work advances the application of AI in personalized medicine and clinical decision support.